Open Access
CC BY 4.0 · Endoscopy 2025; 57(S 01): E841-E842
DOI: 10.1055/a-2650-9610
E-Videos

Reintervention for self-expandable metal stent dysfunction caused by tumor ingrowth using endoscopic holmium laser ablation

Takeshi Ogura
1   Endoscopy Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan (Ringgold ID: RIN38588)
2   2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan (Ringgold ID: RIN13010)
,
2   2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan (Ringgold ID: RIN13010)
,
Takafumi Kanadani
2   2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan (Ringgold ID: RIN13010)
,
Junichi Nakamura
2   2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan (Ringgold ID: RIN13010)
,
Hiroki Nishikawa
2   2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan (Ringgold ID: RIN13010)
› Author Affiliations
 

In cases of an occluded uncovered self-expandable metal stent (UCSEMS), reintervention is sometimes performed deploying additional UCSEMSs. However, re-intervention for an occluded UCSEMS due to tumor ingrowth might sometimes be challenging. Moreover, this procedure might be more difficult for patients who have undergone multiple SEMS deployments using the stent-in-stent technique. However, because of patients’ longer survival due to improvements in systemic chemotherapy such as immune checkpoint inhibitors, the frequency of reintervention may be increased. Endobiliary radiofrequency ablation may be one of the options to treat tumor ingrowth [1] [2], although long-term outcomes are still unclear. Compared with endobiliary radiofrequency ablation, an endoscopic holmium laser procedure may be safely performed because of direct visualization by cholangioscopy. A case of successful reintervention after multiple UCSEMS deployments by endoscopic holmium laser ablation is described.

A 92-year-old man previously underwent multiple UCSEMS deployments for cholangiocarcinoma. He also underwent seven reintervention sessions. He developed a stent obstruction, and therefore re-intervention was attempted ([Fig. 1]). Guidewire insertion into the biliary tract was successfully performed, followed by cholangioscope insertion. On cholangioscopy, tumor ingrowth was observed ([Fig. 2]). Because the cholangioscope could not be advanced into the hepatic hilar site due to tumor ingrowth, tumor ablation using a holmium laser was attempted ([Fig. 3]). After tumor ablation, the tumor disappeared ([Fig. 4]), and the cholangioscope could be advanced into the right hepatic bile duct. However, tumor ingrowth was also observed at this site. Tumor ablation using the holmium laser was again attempted, and the tumor was successfully ablated without any adverse events. Cholangiography showed no stricture ([Fig. 5], [Video 1]). Therefore, additional stent deployment was not performed. Stent patency was obtained for four months until the patient’s death.

Zoom
Fig. 1 Deployment of multiple uncovered self-expandable metal stents.
Zoom
Fig. 2 On cholangioscopy, tumor ingrowth is observed.
Zoom
Fig. 3 Tumor ablation using a holmium laser is attempted.
Zoom
Fig. 4 After tumor ablation, the tumor has disappeared.
Zoom
Fig. 5 Cholangiography shows no stricture.
Reintervention for self-expandable metal stent dysfunction caused by tumor ingrowth using endoscopic holmium laser ablation.Video 1

In conclusion, tumor ablation using a holmium laser can be one of the options as a reintervention technique for an occluded UCSEMS.

Endoscopy_UCTN_Code_TTT_1AR_2AZ

E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/).

This section has its own submission website at https://mc.manuscriptcentral.com/e-videos.


Conflict of Interest

The authors declare that they have no conflict of interest.


Correspondence

Takeshi Ogura, MD
Endoscopy Center, Osaka Medical and Pharmaceutical University Hospital
2-7 Daigakuchou, Takatsukishi
Osaka 569-8686
Japan   

Publication History

Article published online:
29 July 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany


Zoom
Fig. 1 Deployment of multiple uncovered self-expandable metal stents.
Zoom
Fig. 2 On cholangioscopy, tumor ingrowth is observed.
Zoom
Fig. 3 Tumor ablation using a holmium laser is attempted.
Zoom
Fig. 4 After tumor ablation, the tumor has disappeared.
Zoom
Fig. 5 Cholangiography shows no stricture.